# Maximus, Inc.: Form 10-Q for the period ended Jun 30, 2021

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2021-08-05
- Accepted by EDGAR: Aug 5, 2021, 17:02 ET
- Period: 2021-06-30
- Accession: 0001032220-21-000091
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000103222021000091/mms-20210630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000103222021000091/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2021-04-01 to 2021-06-30 | $1.24bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2020-10-01 to 2021-06-30 | $3.15bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2021-04-01 to 2021-06-30 | $951.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2020-10-01 to 2021-06-30 | $2.42bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2021-04-01 to 2021-06-30 | $291.9m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2020-10-01 to 2021-06-30 | $728.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2021-04-01 to 2021-06-30 | $140.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2020-10-01 to 2021-06-30 | $364.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2021-04-01 to 2021-06-30 | $139.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2020-10-01 to 2021-06-30 | $340.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2021-04-01 to 2021-06-30 | $3.1m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2020-10-01 to 2021-06-30 | $4.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2021-04-01 to 2021-06-30 | $33.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2020-10-01 to 2021-06-30 | $87.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2021-04-01 to 2021-06-30 | $94.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2020-10-01 to 2021-06-30 | $239.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2021-04-01 to 2021-06-30 | $1.51 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2020-10-01 to 2021-06-30 | $3.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2021-04-01 to 2021-06-30 | $1.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2020-10-01 to 2021-06-30 | $3.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2021-04-01 to 2021-06-30 | 62,453,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2020-10-01 to 2021-06-30 | 62,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2020-10-01 to 2021-06-30 | $246.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2020-10-01 to 2021-06-30 | $32.1m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months, 2020-10-01 to 2021-06-30 | $3.4m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2021-06-30 | $96.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-06-30 | $1.31bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-06-30 | $4.37bn | us-gaap:Assets |
| Current liabilities | at 2021-06-30 | $860.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-06-30 | $2.92bn | us-gaap:Liabilities |
| Long-term debt | at 2021-06-30 | $1.63bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2021-06-30 | $60.6m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2021-06-30 | $1.45bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 42,668 characters.

*The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2020, which was filed with the Securities and Exchange Commission on November 19, 2020.*

### Business Overview

We are a U.S.-based global company with approximately 34,000 employees dedicated to helping governments on four continents administer their health and human services programs. We help people connect to and interact with vital government programs so that they receive the necessary support they are eligible to receive. The demand for the provision of these services is driven by numerous factors including aging populations with complex healthcare needs; rising living standards in emerging markets creating new demands for our services; growing complexity of programs, such as evolving eligibility requirements; the creation of new programs and initiatives such as long-term services and support, and the urgent need to support a surge in demand to help governments respond to the public health emergency. The coronavirus (COVID-19) global pandemic has required governments to implement new operational models to ensure public safety and this has led to an increased appetite for public-private partnerships due to availability of increased flexibility, scalability, and accountability, particularly in a time when government customers are looking for ways to dramatically increase services to meet the surging demand and subsequent strain on their agencies.

Maximus operates in a sector with relatively few environmental and social-issue risks but many opportunities, particularly ones that enable us to improve the lives of individuals and families, and provide meaningful opportunities to our employees. We run programs that connect people with disabilities and long-term health conditions to sustainable, long-term employment and we help people, including many of society's most vulnerable populations, access, connect to, and use government benefit programs, such as Medicaid and Medicare.

The pandemic resulted in both favorable and unfavorable impacts to Maximus. Underscoring the importance of the services we provide, many of our U.S. contracts were designated as ‘‘essential’’ by government agencies in the midst of the pandemic. Continued operations of these programs ensure vulnerable individuals and families can access vital healthcare and safety-net services during these uncertain times. Due to the pandemic, some of the programs we support experienced temporary changes at the direction of our customers which reduced volume, revenue, and profit on certain large programs. However, we have also been successful in winning new contracts tied to the urgent need to support public health initiatives such as contact tracing, disease investigation, unemployment insurance programs, and supporting efforts around vaccine administration, scheduling, and registration to help governments slow the spread of COVID-19. The individuals and families served under these programs are those considered some of the most vulnerable to COVID-19, and we believe our operations support programs that are essential for their safety and wellbeing.

Our primary objective amidst this pandemic is to protect our employees while ensuring global business continuity of our essential services to help vulnerable individuals and taking responsible action to stop the virus from spreading further. The safety and wellbeing of our employees are paramount, and we made several sweeping changes to better serve our employees.

### Acquisitions

To supplement our core business, we have an active program to identify potential strategic acquisitions. Our acquisitions have successfully enabled us to increase future organic growth, as well as expand our business processes, knowledge, and client relationships into adjacent markets and new geographies.

In March 2021, Maximus closed our acquisition of the Federal division of Attain, LLC (Attain). This acquisition expanded Maximus’ technology capabilities in application development and modernization, enterprise business solutions, cybersecurity, and the data sciences including advanced analytics & machine learning. These capabilities address U.S. Federal IT spending imperatives while also being applicable to our business process outsourcing (BPO) solutions. They add to our existing portfolio of technology solutions comprised of modernization of systems and information technology infrastructure; infrastructure operations and support; software development, operations and support; and data analytics. Attain’s reputation as an innovator and experience as a forward-thinking technology provider are valuable additions to the U.S. Federal Services Segment and Maximus as a whole.

On May 28, 2021, Maximus completed the acquisition of VES, a leading provider of medical disability examinations to determine Veterans’ eligibility for compensation and pension benefits. The acquisition broadens our independent and conflict free clinical BPO services at scale. The acquisition provides us with key qualifications that we believe will assist governments with challenges they face around shifting demographic and policy priorities. VES’s connection with the U.S. Department of Veterans Affairs allows Maximus to pursue new opportunities with a wider set of customers, both federally and state, that are seeking independent and clinically based services. VES complements the Attain combination by expanding our support of the VA and creating new opportunities to apply digital solutions to improve citizen services.

In fiscal year 2020, we acquired InjuryNet Australia Pty Limited (InjuryNet) in Australia and Index Root Korea Co. (Index Root) in South Korea, which we integrated into our Outside the U.S. Segment. The InjuryNet acquisition broadens our customer offerings to include health oriented contracts in Australia and the Index Root acquisition enabled entry into South Korea to provide employment services.

### Financial Overview

The acquisitions of VES and Attain have affected our results as follows:

- Our year to date revenue and gross profit includes an additional $120.6 million and $36.6 million, respectively, attributable to these two acquisitions, which will be included in our U.S. Federal Services Segment. Given the integration of these businesses into our cost structure, it is impracticable to calculate the effect of the acquisitions on our operating income.
- We incurred acquisition expenses through June 2021, of $8.8 million relating to these transactions, principally for legal, advisory and insurance services.
- Our intangible assets increased by $769.0 million, which will be amortized over the next 14 years.
- These acquisitions have been funded by an increase in our debt. At the beginning of this fiscal year, we had no outstanding indebtedness within the United States and some international balances to cover acquisitions and general working capital matters. To fund the acquisitions, we took on $1.5 billion of fixed term debt and entered into a new revolving credit facility. While we anticipate reducing this debt over the next few quarters, the cost of this debt, including interest expenses and the cost of the debt facilities, have increased our financing costs. To comply with the terms of the VES purchase agreement, we entered into a financing commitment arrangement (the interim financing). The cost of this interim facility was approximately $8.5 million, which has been recorded in "other (income)/expense, net" on our consolidated statement of operations.

The COVID-19 pandemic, and the responses of our customers, has had an effect on our results for the three and nine months ended June 30, 2021.

- We have continued to experience significant revenue growth in new work to assist governments in their COVID-19 response efforts. This has mitigated the effect of declines in some of our established programs, particularly those which rely upon payments per transaction. The COVID-19 response work in the three and nine months ended June 30, 2021, resulted in approximately $460 million and $860 million of revenue, respectively. We anticipate COVID response work will contribute more than $1 billion for the full fiscal year 2021.
- Our Outside the U.S. Segment has experienced the most significant negative impact of the COVID-19 pandemic. In the second quarter of fiscal year 2020, we revised our estimates of job seekers who are likely to achieve employment outcomes, resulting in a decline in our estimated outcomes and a consequent decline in revenue of approximately $24.0 million. During fiscal year 2021, this business has demonstrated significant recovery principally through the improvements in performance in Australia.

Our organic growth has been partially offset by the anticipated decline in revenues from our Census Questionnaire Assistance (CQA) contract, which has concluded during fiscal year 2021. We earned $170.4 million and $313.2 million less revenue in the three and nine months ended June 30, 2021, respectively, compared to the respective periods in fiscal year 2020. In addition, a number of contracts in the start-up phase within our Outside the U.S. Segment have reported expected losses as these projects commence. They are anticipated to reach profitability in fiscal year 2022.

### Results of Operations

### Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

*(dollars in thousands, except per share data)*

|  | Three Months Ended June 30, 2021 | 2020 | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $1,243,520 | $901,337 | $3,148,354 | $2,537,701 |
| Cost of revenue | 951,664 | 715,734 | 2,419,785 | 2,023,550 |
| Gross profit | 291,856 | 185,603 | 728,569 | 514,151 |
| Gross profit percentage | 23.5% | 20.6% | 23.1% | 20.3% |
| Selling, general and administrative expenses | 140,129 | 89,582 | 364,498 | 283,662 |
| Selling, general and administrative expense as a percentage of revenue | 11.3% | 9.9% | 11.6% | 11.2% |
| Amortization of intangible assets | 12,132 | 8,712 | 23,718 | 26,734 |
| Operating income | 139,595 | 87,309 | 340,353 | 203,755 |
| Operating income percentage | 11.2% | 9.7% | 10.8% | 8.0% |
| Interest expense | 3,087 | 616 | 4,049 | 1,565 |
| Other (expense)/income, net | (8,289) | (671) | (9,584) | 621 |
| Income before income taxes | 128,219 | 86,022 | 326,720 | 202,811 |
| Provision for income taxes | 33,724 | 21,558 | 87,534 | 51,963 |
| Effective income tax rate | 26.3% | 25.1% | 26.8% | 25.6% |
| Net income | $94,495 | $64,464 | $239,186 | $150,848 |
| Basic earnings per share | $1.52 | $1.04 | $3.86 | $2.38 |
| Diluted earnings per share | $1.51 | $1.04 | $3.84 | $2.37 |

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail.

Changes in revenue, cost of revenue, and gross profit for the three months ended June 30, 2021, are summarized below.

*Dollars in thousands*

*Dollars in thousands*

*Dollars in thousands*

|  | Revenue | Percentage change | Cost of Revenue | Percentage change | Gross Profit | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended June 30, 2020 | $901,337 |  | $715,734 |  | $185,603 |  |
| Effect of Census Questionnaire Assistance 2020 (CQA) contract | (170,385) | (18.9)% | (138,431) | (19.3)% | (31,954) | (17.2)% |
| Organic effect | 387,163 | 43.0% | 284,616 | 39.8% | 102,547 | 55.3% |
| Net acquired growth | 102,750 | 11.4% | 71,730 | 10.0% | 31,020 | 16.7% |
| Currency effect compared to the prior period | 22,655 | 2.5% | 18,015 | 2.5% | 4,640 | 2.5% |
| Three months ended June 30, 2021 | $1,243,520 | 38.0% | $951,664 | 33.0% | $291,856 | 57.2% |

23

Changes in revenue, cost of revenue, and gross profit for the nine months ended June 30, 2021, are summarized below.

*Dollars in thousands*

*Dollars in thousands*

*Dollars in thousands*

|  | Revenue | Percentage change | Cost of Revenue | Percentage change | Gross Profit | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Nine Months Ended June 30, 2020 | $2,537,701 |  | $2,023,550 |  | $514,151 |  |
| Effect of Census Questionnaire Assistance 2020 (CQA) contract | (313,155) | (12.3)% | (263,483) | (13.0)% | (49,672) | (9.7)% |
| Organic effect | 754,594 | 29.7% | 534,434 | 26.4% | 220,160 | 42.8% |
| Net acquired growth | 125,092 | 4.9% | 90,635 | 4.5% | 34,457 | 6.7% |
| Currency effect compared to the prior period | 44,122 | 1.7% | 34,649 | 1.7% | 9,473 | 1.8% |
| Nine Months Ended June 30, 2021 | $3,148,354 | 24.1% | $2,419,785 | 19.6% | $728,569 | 41.7% |

Our cost of revenue includes direct costs related to labor, subcontractor labor, outside vendors, rent, and other direct costs.

Selling, general and administrative expense (SG&A) consists of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. Federal Government and many states, we allocate these costs using a methodology driven by the Federal Cost Accounting Standards.

Our SG&A expense has increased year-over-year due primarily to:

- acquisition expenses, primarily due to Attain and VES, as well as the additional cost base from these acquired businesses;
- severance expenses in the United States in the first quarter of fiscal year 2021, which are expected to provide a benefit for the remainder of the fiscal year;
- information technology initiatives, including migration of data systems to the cloud;
- additional costs to address the COVID-19 pandemic;
- increases in business development activity to both bolster our technical skills and plan for increased bidding activity; and
- increases in our scope of operations, which increases our administrative base.

Our amortization of intangible assets declined after the first fiscal quarter of 2021 as a large asset related to the U.S. Census contract was fully amortized. The acquisitions of VES and Attain are expected to add an annual amortization charge of $65.5 million. To assist users of our financial statements going forward, we will present results excluding the effects of the amortization of intangible assets.

*(dollars in thousands, except per share data)*

|  | Three Months Ended June 30, 2021 | 2020 | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Operating income | $139,595 | $87,309 | $340,353 | $203,755 |
| Amortization of intangible assets | 12,132 | 8,712 | 23,718 | 26,734 |
| Operating income excluding amortization of intangible assets - non-GAAP | $151,727 | $96,021 | $364,071 | $230,489 |
| Net income | $94,495 | $64,464 | $239,186 | $150,848 |
| Amortization of intangible assets adjusted for income taxes | 8,941 | 6,529 | 17,364 | 19,884 |
| Net income excluding amortization of intangible assets - non-GAAP | $103,436 | $70,993 | $256,550 | $170,732 |
| Diluted earnings per share | $1.51 | $1.04 | $3.84 | $2.37 |
| Effect of amortization of intangible assets on diluted earnings per share | 0.15 | 0.10 | 0.28 | 0.31 |
| Diluted earnings per share excluding amortization of intangible assets - non-GAAP | $1.66 | $1.14 | $4.12 | $2.68 |

Our interest expense increased as we borrowed funds to acquire VES and Attain. We anticipate an additional $10 million of interest expense for the remainder of the fiscal year. As part of the VES acquisition, we incurred additional charges related to the interim financing. The $8.5 million cost of this funding was recorded within "other (income)/expense, net" on our consolidated statement of operations.

Our effective income tax rate for the three months ended June 30, 2021 and 2020, was 26.3% and 25.1%, respectively. Our effective income tax rate for the nine months ended June 30, 2021 and 2020, was 26.8% and 25.6%, respectively. Our projected annual effective income tax rate for the full fiscal year 2021 is between 25% and 25.5%.

### U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services (BPS) such as program administration, appeals and assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act (ACA), Medicaid, the Children’s Health Insurance Program (CHIP), Temporary Assistance to Needy Families (TANF), and child support programs. Addressing societal macro trends such as aging populations and rising costs, the segment continues to execute on its clinical evolution strategy by expanding its clinical offerings in public health with new work in contact tracing, disease investigation, and vaccine distribution support services as part of the governments' COVID-19 response efforts. The segment also successfully expanded into the unemployment insurance market, supporting more than 15 states in their unemployment insurance programs.

*(dollars in thousands)*

|  | Three Months Ended June 30, 2021 | 2020 | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $436,338 | $336,950 | $1,269,487 | $957,929 |
| Cost of revenue | 331,524 | 243,921 | 946,231 | 689,856 |
| Gross profit | 104,814 | 93,029 | 323,256 | 268,073 |
| Operating income | 62,208 | 61,033 | 206,601 | 165,440 |
| Gross profit percentage | 24.0% | 27.6% | 25.5% | 28.0% |
| Operating income percentage | 14.3% | 18.1% | 16.3% | 17.3% |

Our revenue and cost of revenue for the three month period ended June 30, 2021, increased 29% and 36%, respectively, compared to the same period in fiscal year 2020. Our revenue and cost of revenue for the nine month period ended June 30, 2021, increased 33% and 37%, respectively, compared to the same period in fiscal year 2020. All growth was organic.

Our growth for the three and nine months ended June 30, 2021, is driven by approximately $164 million and $450 million of COVID-19 response work, respectively. This work is short-term and has offset revenue declines resulting from constraints on many of our core programs. Among other factors, we are reporting lower volumes of transactions on redetermination contracts as states have paused Medicaid redeterminations as a condition for receiving enhanced U.S. Federal matching funds. In certain cases, redeterminations provide a significant part of our activity within volume-based contracts. The decline in profit margins is principally from these core programs operating at reduced capacity. As the pandemic restrictions ease, we anticipate that our short-term response work will decline and our core programs will recover, but the timing of the recovery is uncertain.

We anticipate operating income margins for the full fiscal year 2021 will be between 16% and 17%.

### U.S. Federal Services Segment

From technology solutions to program administration and operations, our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal agencies better deliver on their mission. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage within the Medicare Appeals portfolio which continues to be managed within this segment. Propelled by the Maximus Attain platform, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the charge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions and manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs. The segment further supports clinical offerings in public health with new work supporting the U.S. Federal Government's COVID-19 response efforts. This included expanded work with the Centers for Disease Control and Prevention (CDC) for their helpline and increased support for the IRS Wage and Investment Division's response efforts to general inquiries regarding the Coronavirus Aid Relief & Economic Security (CARES) Act and Economic Impact Payment Service Plan.

*(dollars in thousands)*

|  | Three Months Ended June 30, 2021 | 2020 | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $617,601 | $450,143 | $1,352,982 | $1,210,105 |
| Cost of revenue | 461,825 | 365,420 | 1,040,577 | 977,603 |
| Gross profit | 155,776 | 84,723 | 312,405 | 232,502 |
| Operating income | 86,129 | 39,233 | 139,528 | 101,047 |
| Gross profit percentage | 25.2% | 18.8% | 23.1% | 19.2% |
| Operating income percentage | 13.9% | 8.7% | 10.3% | 8.4% |

26

Changes in revenue, cost of revenue, and gross profit for the three months ended June 30, 2021, are summarized below.

*Dollars in thousands*

*Dollars in thousands*

*Dollars in thousands*

|  | Revenue | Percentage change | Cost of Revenue | Percentage change | Gross Profit | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three months ended June 30, 2020 | $450,143 |  | $365,420 |  | $84,723 |  |
| Effect of CQA contract | (170,385) | (37.9)% | (138,431) | (37.9)% | (31,954) | (37.7)% |
| Organic growth from other contracts | 236,222 | 52.5% | 165,444 | 45.3% | 70,778 | 83.5% |
| Net acquisitions and disposals | 101,621 | 22.6% | 69,392 | 19.0% | 32,229 | 38.0% |
| Three months ended June 30, 2021 | $617,601 | 37.2% | $461,825 | 26.4% | $155,776 | 83.9% |

Changes in revenue, cost of revenue, and gross profit for the nine months ended June 30, 2021, are summarized below.

*Dollars in thousands*

*Dollars in thousands*

*Dollars in thousands*

|  | Revenue | Percentage change | Cost of Revenue | Percentage change | Gross Profit | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Nine months ended June 30, 2020 | $1,210,105 |  | $977,603 |  | $232,502 |  |
| Effect of CQA contract | (313,155) | (25.9)% | (263,483) | (27.0)% | (49,672) | (21.4)% |
| Organic growth from other contracts | 338,310 | 28.0% | 244,401 | 25.0% | 93,909 | 40.4% |
| Net acquisitions and disposals | 117,722 | 9.7% | 82,056 | 8.4% | 35,666 | 15.3% |
| Nine months ended June 30, 2021 | $1,352,982 | 11.8% | $1,040,577 | 6.4% | $312,405 | 34.4% |

Our revenue and cost of revenue for the three month period ended June 30, 2021, increased 37% and 26%, respectively, compared to the same period in fiscal year 2020. Our revenue and cost of revenue for the nine month period ended June 30, 2021, increased 11.8% and 6.4%, respectively, compared to the same period in fiscal year 2020. The primary drivers were:

- As anticipated, the CQA (U.S. Census) contract has ended.
- We estimated that our incremental revenue from assisting the U.S. Federal Government with its COVID-19 response for the three and nine months ended June 30, 2021 was $280 million and $370 million, respectively. This short-term work has earned relatively high margins, which has offset the tempering of margins on performance-based contracts, such as independent medical reviews for worker's compensation programs that declined sharply since the onset of the pandemic.
- Our results include those of VES (from May 28, 2021) and Attain (from March 1, 2021).

We anticipate the operating margin for this segment to be between 10% and 11% for the full fiscal year 2021, due to the benefit of VES's higher margins.

### Outside the U.S. Segment

Delivering support to people from different backgrounds, cultures, and communities, our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker related services. We support programs and deliver services in the United Kingdom (U.K.), including the Health Assessment Advisory Service (HAAS), the Work & Health Programme, Fair Start, and Restart; Australia, including jobactive and the Disability Employment Service; Canada, including Health Insurance British Columbia and the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, and Sweden, where we predominantly provide employment support and job seeker services.

*(dollars in thousands)*

|  | Three Months Ended June 30, 2021 | 2020 | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $189,581 | $114,244 | $525,885 | $369,667 |
| Cost of revenue | 158,315 | 106,393 | 432,977 | 356,091 |
| Gross profit | 31,266 | 7,851 | 92,908 | 13,576 |
| Operating income/(loss) | 8,293 | (5,817) | 27,890 | (33,549) |
| Gross profit percentage | 16.5% | 6.9% | 17.7% | 3.7% |
| Operating income/(loss) percentage | 4.4% | (5.1)% | 5.3% | (9.1)% |

Changes in revenue, cost of revenue, and gross profit for the three months ended June 30, 2021, are summarized below

*Dollars in thousands*

*Dollars in thousands*

*Dollars in thousands*

|  | Revenue | Percentage change | Cost of Revenue | Percentage change | Gross Profit | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | --- |
| Three months ended June 30, 2021 | $114,244 |  | $106,393 |  | $7,851 |  |
| Organic growth | 51,553 | 45.1% | 31,569 | 29.7% | 19,984 | NM |
| Acquired growth | 1,129 | 1.0% | 2,338 | 2.2% | (1,209) | NM |
| Currency effect compared to the prior period | 22,655 | 19.8% | 18,015 | 16.9% | 4,640 | NM |
| Three months ended June 30, 2021 | $189,581 | 65.9% | $158,315 | 48.8% | $31,266 | NM |
| NM - Changes are not meaningful. |  |  |  |  |  |  |

Changes in revenue, cost of revenue, and gross profit for the nine months ended June 30, 2021, are summarized below.

*Dollars in thousands*

*Dollars in thousands*

*Dollars in thousands*

|  | Revenue | Percentage change | Cost of Revenue | Percentage change | Gross Profit | Percentage change |
| --- | ---: | ---: | ---: | ---: | ---: | --- |
| Nine months ended June 30, 2021 | $369,667 |  | $356,091 |  | $13,576 |  |
| Organic growth | 104,726 | 28.3% | 33,658 | 9.5% | 71,068 | NM |
| Acquired growth | 7,370 | 2.0% | 8,579 | 2.4% | (1,209) | NM |
| Currency effect compared to the prior period | 44,122 | 11.9% | 34,649 | 9.7% | 9,473 | NM |
| Nine months ended June 30, 2021 | $525,885 | 42.3% | $432,977 | 21.6% | $92,908 | NM |
| NM - Changes are not meaningful. |  |  |  |  |  |  |

This segment has seen organic growth in revenue and profit, as well as acquired growth and currency benefits during fiscal year 2021.

Much of our revenue growth stems from our employment services contracts, where we are paid based upon our ability to place individuals in long-term sustained employment. Revenue is recognized based on our estimate of the number of individuals whom we anticipate reaching these milestones. As a result, changes in our estimates of our ability to place people in work and the time that this will take can have significant effects on our revenue. As the effects of the COVID-19 pandemic became clear during fiscal year 2020, our revenue was significantly tempered as unemployment rose and available employment opportunities declined. As fiscal year 2021 has progressed, market conditions, particularly within Australia, have provided us with more placements than we anticipated and increased our estimates of future outcomes, increasing our revenue.

These estimates are based upon our current expectations as to how the effects of the pandemic, including regulations adopted by governments and employment practices adopted by employers, will progress. We have typically based our estimates on historical performance. The effects of COVID-19 have limited the extent to which we can rely upon historical performance and, accordingly, our revenue may be more volatile than we have previously experienced.

Our acquired growth is from the acquisition of InjuryNet in Australia in February 2020 and Index Root in South Korea in August 2020.

The weakening of the United States Dollar against the currencies in which we do business outside the U.S. has resulted in year-over-year growth in our revenue and costs.

As pandemic restrictions ease and economies emerge from the pandemic-related lockdowns, we anticipate robust markets for our employment services and a return to pre-pandemic levels for our health assessments services. In addition, we have recently been awarded significant contracts in the United Kingdom under the UK Restart program, in addition to smaller contracts in Italy, Saudi Arabia, South Korea, and Sweden. As is typical, we anticipate that these contracts will incur start-up losses that should impact our fourth fiscal quarter before moving to profitability in the second half of fiscal year 2022. Accordingly, we anticipate this segment will realize an operating loss during the fourth quarter of this fiscal year.

### Liquidity and Capital Resources

Our cash flows for the nine months ended June 30, 2021, include payments of $1.36 billion and $419.1 million to cover our acquisitions of VES and Attain, respectively, supported by $1.68 billion of net financing from our new credit facility. Our new credit facility includes a five year $1.10 billion term loan, a seven year $400.0 million term loan and a $600.0 million revolving credit facility, which is repayable in full in May 2026. Interest on these loans are typically based upon the combination of a fixed margin and a variable rate, which is currently based upon the London Interbank Offering Rate (LIBOR). From July 2021, our fixed rate will be based upon a net total leverage ratio as defined in our credit agreement. At this time, our net total leverage ratio is 2.4:1. We believe that this loan facility, as well as our existing cash flows from operations, will provide us with the ability to sustain our operations and meet the short-term debt repayment requirements. We do not anticipate additional significant acquisition activity in the near term while we integrate the Attain and VES acquisitions and we plan to use most of our free cash flow to pay down debt to reduce our leverage ratio.

At June 30, 2021, we had approximately $96.1 million in unrestricted cash and $400.0 million of liquidity available on our $600.0 million revolving corporate credit facility.

We have no requirement to remit funds from our foreign locations to the United States. Current U.S. law enables us to transfer cash from our foreign locations on a tax-free basis. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

### Cash Flows

The following table provides a summary of our cash flow information for the nine months ended June 30, 2021 and 2020.

*(in thousands)*

| Net cash from/(used in): | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: |
| Operations | $246,659 | $96,083 |
| Investing activities - VES | (1,360,231) | — |
| Investing activities - Attain | (419,097) | — |
| Investing activities - other | (32,278) | (27,412) |
| Financing activities | 1,586,792 | (89,001) |
| Effect of exchange rate changes on cash and cash equivalents | 2,830 | (174) |
| Net increase in cash, cash equivalents, and restricted cash | $24,675 | $(20,504) |

Our cash flows from operations in fiscal year 2020 were tempered by the initial effects of the COVID-19 pandemic, including reductions in our business, delays in collecting cash and additional costs required to continue our operations. Our cash flows from operations in fiscal year 2021 benefited from increased revenues from organic and acquired businesses. On a pro forma basis, our DSO at June 30, 2021 is consistent with that at September 30, 2020 and remains within our target range.

| (in days) | Days Sales Outstanding |
| --- | ---: |
| September 30, 2020 | 77 |
| December 31, 2020 | 75 |
| March 31, 2021 (pro forma to reflect Attain acquisition) | 70 |
| June 30, 2021 (pro forma to reflect VES acquisition) | 77 |
| Target Range | 65 - 80 |

Cash used in investing activities for the nine months ended June 30, 2021, was $1.81 billion, principally for the acquisitions of VES and Attain. We have finalized the purchase price of Attain and paid the balance due to the sellers in the third quarter of fiscal year 2021. We are in the process of estimating our final payment to the sellers of VES.

Cash provided by financing activities in the nine months ended June 30, 2021, was $1.59 billion, compared to $89.0 million of cash used in the comparative period. In May 2021, we entered into a new credit facility comprising up to $2.1 billion in available funds; a five year $1.10 billion term loan, a seven year $400.0 million term loan and a $600.0 million revolving credit facility, which is repayable in full in May 2026. We utilized $200 million of the revolving credit facility at June 2021.

To supplement our statements of cash flows presented on a GAAP basis, we use the measure of free cash flow to analyze the funds generated from operations.

*(in thousands)*

|  | Nine Months Ended June 30, 2021 | 2020 |
| --- | ---: | ---: |
| Cash flows from operations | $246,659 | $96,083 |
| Purchases of property and equipment and capitalized software costs | (32,133) | (28,436) |
| Free cash flow - non-GAAP | $214,526 | $67,647 |

### Critical Accounting Policies and Estimates

As of June 30, 2021, there have been no changes to our critical accounting policies and estimates from those disclosed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020.

Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. On an ongoing basis we evaluate our estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and other long-lived assets, and amounts related to contingencies and income tax liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

### Non-GAAP Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operations, net income or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

In fiscal year 2020, 14% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology which excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year’s results for all foreign businesses using the exchange rates in the prior fiscal year. We refer to this adjusted revenue on a "constant currency basis."

In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We will identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We will identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results excluding transactions from acquisitions or disposals to our prior fiscal year results.

Our recent acquisitions have resulted in significant intangible assets which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. Accordingly, we have calculated our operating profit, net income and earnings per share excluding the effect of the amortization of intangible assets. We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.

Our results in fiscal year 2020 included a significant benefit from the CQA contract as the U.S. Federal Government completed its census. As the pattern of revenue from this contract is significant and non-recurring, we have identified the revenue and related costs and excluded them from the organic growth calculation above. We believe that it is helpful to our investors to understand the effect of this contract on our results.

In order to sustain our cash flows from operations, we require regular refreshing of our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology which combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of the Company’s operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our own common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow.

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days. Where our DSO is affected by acquisitions, such as the VES acquisition in May 2021, we will perform the DSO calculation on a pro forma basis, including the acquired revenue for the fiscal quarter.

As noted above, we have a $2.1 billion corporate credit facility. Our credit agreement includes the defined term Consolidated EBITDA and our calculation of Adjusted EBITDA conforms to the credit agreement definition. We believe our investors appreciate the opportunity to understand the possible restrictions which arise from our credit agreement.

- Adjusted EBITDA is also a useful measure of performance which focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization, and makes for easier comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore the impacts of financing costs.
- The measure of Adjusted EBITA is a step in calculating Adjusted EBITDA and facilitates comparisons to similar businesses as it isolates the amortization effect of business combinations.
- Our corporate credit facility requires us to calculate Adjusted EBITDA on a pro forma basis, as though we had owned any significant acquired business for a full twelve months. Accordingly, we have included the effects of VES and Attain in the table below.

We have provided a reconciliation from net income to Adjusted EBITA, Adjusted EBITDA and Pro Forma Adjusted EBITDA as shown below. Our current credit facilities utilized a different version of EBITDA from that of the credit facility used in prior years.

*(in thousands)*

|  | Nine Months Ended June 30, 2021 | Trailing Twelve Months Ended June 30, 2021 |
| --- | ---: | ---: |
| Net income | $239,186 | $302,847 |
| Interest expense | 4,049 | 4,543 |
| Other (expense)/income, net | 9,584 | 9,362 |
| Provision of income taxes | 87,534 | 108,124 |
| Amortization of intangible assets | 23,718 | 32,618 |
| Stock compensation expense | 20,823 | 26,973 |
| Acquisition-related expenses | 9,597 | 10,056 |
| Gain on sale of a business | — | (12) |
| Adjusted EBITA - non-GAAP | $394,491 | $494,511 |
| Depreciation and amortization of property, plant, equipment and capitalized software | 33,664 | 50,696 |
| Adjusted EBITDA - non-GAAP | $428,155 | $545,207 |
| Pro forma adjusted EBITDA related to acquisitions | 92,398 | 129,364 |
| Pro Forma Adjusted EBITDA - non-GAAP | $520,553 | $674,571 |

32

## Market risk

As filed, 2,900 characters.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates and counterparty risk. We use derivative instruments to manage selected interest rate exposures.

Foreign Currency Risk

At June 30, 2021, we held net assets denominated in currencies other than the U.S. Dollar of $188.7 million. Of this balance, we had net monetary assets of $101.0 million, including cash and cash equivalents $65.0 million. We consider monetary assets to be those which which hold a fair value close to their book value and which represent a recent cash outflow or which will become a cash inflow or outflow within a short period of time. These assets and liabilities are typically cash, billed, billable, and unbilled accounts receivable, current prepaid expenses, operating lease right-of-use assets, accounts payable, accrued compensation, deferred revenue, lease liabilities, and debt.

A hypothetical 10% favorable or unfavorable exchange rate movement across currencies would have a positive or negative effect on our annual comprehensive income of $18.9 million and would increase or decrease our cash and cash equivalents and our net monetary assets by $6.5 million and $10.1 million, respectively.

Interest Rate Risk

Our exposure to market risk for changes in interest rates relates to our outstanding debt. The interest expense associated with the two term loans and revolver will vary with market rates. The Tranche A Term Loan (principal balance $1.10 billion) and the revolver (principal balance of $200.0 million) both have a LIBOR floor of 0% and Tranche B Term Loan (principal balance of $400.0 million) has a LIBOR floor of 0.5%. We have an interest rate swap with a notional amount of $300.0 million related to the Tranche A Term Loan. A rise of interest rate levels would increase our interest expense and a reduction in interest rates to the floor would decrease our interest expense. A hypothetical 100 basis point increase in interest rates would have a negative effect on annual earnings in the amount of $12.3 million and a 100 basis point decrease in interest rates would have a positive impact on annual earnings of $0.9 million. We based this sensitivity calculation on the one month LIBOR rate of 0.087% in accordance with the most recent measurement date specified in the Credit Agreement.

Counterparty Risk

We are exposed to credit losses in the event of nonperformance by the counterparties to our derivative instruments. All of our counterparties have investment grade credit ratings; accordingly, we anticipate that the counterparties will be able to fully satisfy their obligations under the contracts. Our agreements outline the conditions upon which it or the counterparties are required to post collateral. At June 30, 2021, we had no collateral posted with our counterparties related to the derivatives.

## Controls and procedures

As filed, 1,725 characters.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

With the exception of the matter noted below, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

In May 2021, we acquired VES Group, Inc. We are in the process of integrating this business into our existing control environment.

## Risk factors

As filed, 9,060 characters.

In connection with information set forth in this Form 10-Q, the factors discussed below and under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2020, should be considered. The risks included below and in those filings could materially and adversely affect our business, financial condition, and results of operations.

Other than as set forth below, there have been no material changes to the factors discussed in our Annual Report on Form 10-K for the fiscal year ended September 30, 2020, which was filed with the Securities and Exchange Commission on November 19, 2020.

***Risks related to our acquisitions of the Federal business of Attain, LLC (“Attain”) and VES Group Inc. (“VES”).***

*Our indebtedness following the completion of the VES acquisition is significant and could adversely affect our business and our ability to meet our obligations.* In connection with the VES acquisition, we incurred significant additional indebtedness. Our new indebtedness contains financial or other covenants that limit our operational flexibility. In addition, the increased indebtedness of the Company following the VES acquisition could adversely affect us in a number of other ways, including:

- causing us to be less able to take advantage of business opportunities, such as other acquisition opportunities, and to react to changes in market or industry conditions;
- increasing our vulnerability to adverse economic, industry, or competitive developments;
- affecting our ability to pay or refinance debts as they become due during adverse economic, financial market, and industry conditions;
- requiring us to use a larger portion of cash flow for debt service, reducing funds available for other purposes;
- decreasing our profitability and/or cash flow;
- causing us to be disadvantaged compared to competitors with less leverage; and
- limiting our ability to borrow additional funds in the future to fund working capital, capital expenditures, and other general corporate purposes.

*We may experience difficulties in integrating our operations with those of Attain and VES and realizing the expected benefits of these acquisitions.* Although we currently anticipate that both the Attain acquisition and the VES acquisition (the “Acquisitions”) will be accretive to earnings per share in fiscal 2022, this expectation is based on assumptions about Maximus', Attain’s and VES’s business and preliminary estimates, which may change materially. The benefits of the Acquisitions will depend, in part, on our ability to successfully combine the businesses of Attain, VES, and Maximus, which currently operate as independent companies and realize the anticipated benefits, including business opportunities and growth prospects from combining our businesses. We may not achieve these objectives within the anticipated time frame, or may never realize these benefits and the value of our common stock may be harmed.

The Acquisitions involve the integration of Attain’s and VES’s businesses with our existing business, which is expected to be a costly and time-consuming process. The integration may result in material challenges, including, without limitation:

- Our management might have its attention diverted from ongoing business concerns while trying to integrate these operations, and we could experience performance shortfalls at one or all three of the companies as a result of the devotion of management’s attention to the Attain and VES integration efforts.
- The integration process could take longer than anticipated and could result in the loss of key employees, the disruption of each company’s ongoing businesses, tax costs or inefficiencies, or inconsistencies in standards, controls, information technology systems, procedures and policies, any of which could materially adversely affect our ability to maintain relationships with customers, employees or other third parties, or our ability to achieve the anticipated benefits of the transactions, and could harm our financial performance.
- We could encounter unanticipated issues in integrating information technology, communications and other systems that could harm our financial performance.
- If we are unable to successfully or timely integrate our operations with those of Attain and VES, we may incur unanticipated liabilities and be unable to realize the revenue growth, synergies, and other anticipated benefits resulting from the Acquisitions, and our business, results of operations, and financial condition could be materially adversely affected.

*VES currently derives all of its revenue from contracts with the Department of Veterans Affairs (“VA”). If one or more of these contracts with the VA are terminated or are not renewed on favorable terms or at all, if the VA reduces the number of medical examinations allocated to VES under the contracts or if VES receives an adverse finding or review resulting from an audit or investigation, the benefits of the VES acquisition may be adversely affected.* VES’s contracts with the VA are generally intended to run for a fixed number of years and may be extended for an additional specified number of years if the contracting entity or its agent elects to do so. When VES’s contracts with the VA expire, they may be opened for bidding by competing providers, and there is no guarantee that the contracts will be renewed or extended. The VA may also elect to open the bidding process earlier than anticipated, resulting in increased competition prior to the anticipated end of the current contracts. Competitors may buy their way into the market by submitting bids with lower pricing. Even if VES’s responsive bids are successful, the bids may be based upon assumptions or other factors which could result in the contracts being less profitable than we had anticipated.

VES’s reputation and relationship with the VA are key factors in maintaining and growing its revenues. Negative press reports or publicity, regardless of accuracy, which could pertain to employee or service provider misconduct, conflicts of interest, poor contract performance, deficiencies in services, information security breaches, or other aspects of its business, could harm its reputation, particularly with the VA. If VES’s reputation is negatively affected, the VA could decrease or cease its business with VES. VES is also subject to various reviews, audits, and investigations to verify its compliance with the terms of its contracts with various governmental agencies, as well as compliance with applicable laws and regulations. Any adverse review, audit, or investigation could result in, among other things: cancellation of VES’s contracts; refunding of amounts that have been paid pursuant to its contracts; imposition of fines, penalties and other sanctions on VES; loss of its right to participate in various programs; loss of one or more of its licenses; lowered quality ratings; or changes to the way it does its business. In addition, under government procurement regulations and practices, a negative determination resulting from a government audit of the business practices could result in a contractor being fined, debarred, and/or suspended from being able to bid on, or be awarded, new government contracts for a period of time.

If any of the foregoing occurs, the volume of VES’s business with the VA could decrease and its business, future revenues, financial condition, and growth prospects could be adversely affected, causing the benefits to Maximus of the VES acquisition to be adversely affected.

*In connection with the Acquisitions, we may be required to take write-downs or write-offs, restructuring and impairment, or other charges that could negatively affect our business, assets, liabilities, prospects, outlook, financial condition, and results of operations.* Although we have conducted extensive due diligence on Attain and VES in connection with the Acquisitions, we cannot assure that this diligence revealed all material issues that may be present, that it would be possible to uncover all material issues through customary due diligence, or that factors outside of our control will not later arise. We have also purchased representations and warranties insurance policies in connection with the Acquisitions, but there is no assurance that those policies will cover any losses we might experience from breaches of the sellers’ representations and warranties or otherwise arising from the Acquisitions. Even if our due diligence successfully identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary risk analysis. Further, as a result of the Acquisitions, purchase accounting, and the proposed operation of the combined company after closing, we may be required to take write-offs or write-downs, restructuring and impairment or other charges that could negatively affect business, assets, liabilities, prospects, outlook, financial condition and results of operations after closing of the Acquisitions.

Filed Aug 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001032220-21-000091. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
